Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMUEL G DOZIER

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1043283039
CMS profile
819845
Location
FLORENCE, SC

General Payments · PY2019–2024

$2,557.75

  • Reported across 164 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$668.36

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $668.36 39

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15.78 1
PY2020 $307.97 24
PY2021 $598.99 41
PY2022 $457.44 29
PY2023 $509.21 30
PY2024 $668.36 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $15.53 02/06/2024 Food and Beverage Undisputed 01/23/2026 1124809835 CMS
Abbott Laboratories $14.47 11/26/2024 Food and Beverage Undisputed 01/23/2026 1124809837 CMS
ABBVIE INC. $15.74 04/23/2024 Food and Beverage Undisputed 01/23/2026 1103658120 CMS
ABBVIE INC. $15.20 08/23/2024 Food and Beverage Undisputed 01/23/2026 1103658122 CMS
Amgen Inc. $14.08 02/19/2024 Food and Beverage Undisputed 01/23/2026 1115585324 CMS
Amgen Inc. $13.19 03/19/2024 Food and Beverage Undisputed 01/23/2026 1117544392 CMS
Amgen Inc. $14.88 05/29/2024 Food and Beverage Undisputed 01/23/2026 1117544394 CMS
AstraZeneca Pharmaceuticals LP $13.49 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104750590 CMS
AstraZeneca Pharmaceuticals LP $17.71 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104541668 CMS
Boston Scientific Corporation $21.67 04/23/2024 Food and Beverage Undisputed 01/23/2026 1092380804 CMS
Corcept Therapeutics $19.31 10/28/2024 Food and Beverage Undisputed 01/23/2026 1117769868 CMS
Corcept Therapeutics $22.62 11/25/2024 Food and Beverage Undisputed 01/23/2026 1117769922 CMS
CVRx, Inc. $19.00 06/17/2024 Food and Beverage Undisputed 01/23/2026 1128520400 CMS
CVRx, Inc. $18.89 11/20/2024 Food and Beverage Undisputed 01/23/2026 1128520402 CMS
Esperion Therapeutics, Inc. $16.60 03/04/2024 Food and Beverage Undisputed 01/23/2026 1129433548 CMS
Esperion Therapeutics, Inc. $15.68 06/19/2024 Food and Beverage Undisputed 01/23/2026 1129433550 CMS
Esperion Therapeutics, Inc. $15.46 07/24/2024 Food and Beverage Undisputed 01/23/2026 1129433552 CMS
Esperion Therapeutics, Inc. $19.63 08/22/2024 Food and Beverage Undisputed 01/23/2026 1129433554 CMS
Esperion Therapeutics, Inc. $16.66 11/08/2024 Food and Beverage Undisputed 01/23/2026 1129433556 CMS
Esperion Therapeutics, Inc. $18.36 12/11/2024 Food and Beverage Undisputed 01/23/2026 1129433558 CMS
GlaxoSmithKline, LLC. $14.57 02/26/2024 Food and Beverage Undisputed 01/23/2026 1116436769 CMS
GlaxoSmithKline, LLC. $16.02 04/26/2024 Food and Beverage Undisputed 01/23/2026 1116131306 CMS
GlaxoSmithKline, LLC. $13.84 04/26/2024 Food and Beverage Undisputed 01/23/2026 1116584461 CMS
GlaxoSmithKline, LLC. $16.01 08/05/2024 Food and Beverage Undisputed 01/23/2026 1116443389 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.65 05/28/2024 Food and Beverage Undisputed 01/23/2026 1143218129 CMS
Lilly USA, LLC $16.62 04/30/2024 Food and Beverage Undisputed 01/23/2026 1135342501 CMS
Lilly USA, LLC $13.76 05/30/2024 Food and Beverage Undisputed 01/23/2026 1135412329 CMS
Lilly USA, LLC $13.26 06/03/2024 Food and Beverage Undisputed 01/23/2026 1135387073 CMS
Novo Nordisk Inc $13.18 01/08/2024 Food and Beverage Undisputed 01/23/2026 1097046294 CMS
Novo Nordisk Inc $23.30 02/29/2024 Food and Beverage Undisputed 01/23/2026 1096566736 CMS
Novo Nordisk Inc $19.29 08/19/2024 Food and Beverage Undisputed 01/23/2026 1097139866 CMS
Paratek Pharmaceuticals, Inc. $15.40 09/18/2024 Food and Beverage Undisputed 01/23/2026 1113898689 CMS
PFIZER INC. $18.50 10/01/2024 Food and Beverage Undisputed 01/23/2026 1132088453 CMS
Phathom Pharmaceuticals, Inc. $14.20 05/30/2024 Food and Beverage Undisputed 01/23/2026 1151056781 CMS
Radius Health, Inc. $17.47 04/11/2024 Food and Beverage Undisputed 01/23/2026 1089989775 CMS
SHIELD THERAPEUTICS INC $14.07 08/20/2024 Food and Beverage Undisputed 01/23/2026 1150142774 CMS
SHIELD THERAPEUTICS INC $13.77 09/23/2024 Food and Beverage Undisputed 01/23/2026 1150146937 CMS
Sumitomo Pharma America, Inc. $27.79 06/18/2024 Food and Beverage Undisputed 01/23/2026 1148846665 CMS
Sumitomo Pharma America, Inc. $29.49 11/13/2024 Food and Beverage Undisputed 01/23/2026 1148846667 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.